The LifeLines Cohort Study: Prevalence and treatment of cardiovascular disease and risk factors M. Yldau van der Ende, Minke H.T. Hartman, Yanick Hagemeijer, Laura M.G. Meems, Hendrik Sierd de Vries, Ronald P. Stolk, Rudolf A. de Boer, Anna Sijtsma, Peter van der Meer, Michiel Rienstra, Pim van der Harst International Journal of Cardiology Volume 228, Pages 495-500 (February 2017) DOI: 10.1016/j.ijcard.2016.11.061 Copyright © 2016 Swiss Tropical and Public Health Institute Terms and Conditions
Fig. 1 Population distribution in the Netherlands in 2010 and population distribution in the LifeLines Cohort Study population. International Journal of Cardiology 2017 228, 495-500DOI: (10.1016/j.ijcard.2016.11.061) Copyright © 2016 Swiss Tropical and Public Health Institute Terms and Conditions
Fig. 2 Body mass index distribution for males and females in the middle and older age category in the LifeLines Cohort Study, BMI=body mass index. International Journal of Cardiology 2017 228, 495-500DOI: (10.1016/j.ijcard.2016.11.061) Copyright © 2016 Swiss Tropical and Public Health Institute Terms and Conditions
Fig. 3 Mean SCORE and CVD per age category in the LifeLines Cohort Study. SCORE=Systematic Coronary Risk Evaluation Project; CVD=cardiovascular disease. International Journal of Cardiology 2017 228, 495-500DOI: (10.1016/j.ijcard.2016.11.061) Copyright © 2016 Swiss Tropical and Public Health Institute Terms and Conditions